Data

The Schaeffer Center is charged with producing relevant, rigorous research of consequence. The Center identifies opportunities to increase value in healthcare delivery, improve performance of healthcare markets, improve health outcomes and reduce disparities, and foster better pharmaceutical policy and regulation through data-drive, interdisciplinary research. Below are key data points from recent research in each of these areas. Click the card to learn more about the analysis behind each point.

The Schaeffer Center’s dedication to assembling the nation’s best researchers and developing a robust data infrastructure is what feeds its ability to produce research with consequence. Learn more here.

Featured Data

Difference between monthly out-of-pocket costs in traditional Medicare versus Medicare Advantage for a typical beneficiary in 2019

increase in prescription fills for semaglutide products between January 2021 and December 2023.

Chart: Monthly fills of Ozempic, Wegovy and Rybelsus

Post-Dobbs decline in emergency contraceptive prescription fills in states with the most restrictions on abortion.*

state with the most restrictions on abortion

of hospitals promote interest-bearing medical payment products (MPPs), such as credit cards and loans, on their website.

Prevalence of medical payment products

increase in Medicare Advantage beneficiaries diagnosed with dementia after reintroduction of "risk adjustment"

The median time of COVID-19 infectivity among children aged 7-18

Annual overpayments to Medicare Advantage (MA) plans, estimated by USC Schaeffer experts

The value to society of Medicare coverage of weight loss drugs over 10 years.

of rural counties had Medicare Advantage penetration of 45% or greater in 2022.

of U.S. retail prescription claims are managed by the top three pharmacy benefit managers.

excess life years lost since the start of the pandemic.

of insulin expenditures went to middlemen in 2018.